Responsibilities and priorities across global markets (ex-U.S.) shape where we invest, how we enter, and how we win with payers and partners.

• Global Commercial Strategy (Ex-U.S.): lead Global ex-US market identification, prioritization, and segmentation across geographies.
• Develop and execute go-to-market strategies tailored by geography and indication.
• Define optimal pathways to market entry, including indication prioritization.
• Provide Commercial support to inform lifecycle prioritization.

• Cross-Functional Leadership: Partner with Clinical and Regulatory to shape development programs aligning with commercial objectives and regulatory requirements.
• Influence clinical study design and sequencing to maximize global commercial opportunity.
• Ensure alignment across stakeholders to maintain a unified strategy.
• Partner with Market Access to evaluate pricing and reimbursement dynamics across international markets, including health technology assessment (HTA) environments.
• Identify and mitigate risks related to international reference pricing and MFN implications.

• Business Development & Partnerships: Lead business development to identify, evaluate, and secure strategic partners for market entry.
• Structure and support partnership models (licensing, co-promotion, regional partnerships).
• Manage partner strategy to ensure successful execution in priority markets.

• Strategic Analytics & Decision-Making: Conduct market assessments, including epidemiology, competitive landscape, and access dynamics.
• Develop commercial forecasts and scenario analyses to inform prioritization and investment decisions.
• Provide strategic recommendations to senior leadership based on data-driven insights.